{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:32:53Z","timestamp":1792513973734,"version":"4.5.0"},"reference-count":42,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.2169\/internalmedicine.1447-18","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:30:24Z","timestamp":1539729024000},"page":"487-495","source":"Crossref","is-referenced-by-count":7,"title":["C-reactive Protein Can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding"],"prefix":"10.2169","volume":"58","author":[{"given":"Takeshi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Koukan Hospital, Japan"},{"name":"Department of Gastroenterology and Hepatology, Itabashi Chuo Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Machida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Itabashi Chuo Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Itabashi Chuo Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Oi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Itabashi Chuo Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"A. Fujino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Itabashi Chuo Medical Center, Japan"},{"name":"Department of Internal Medicine, Hasune Royal Clinic, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sato M, Tateishi R, Yasunaga H, et al. Variceal hemorrhage: analysis of 9987 cases from a Japanese nationwide database. Hepatol Res 45: 288-293, 2015.","DOI":"10.1111\/hepr.12357"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jairath V, Rehal S, Logan R, et al. Acute variceal haemorrhage in the United Kingdom: patients characteristics, management and outcomes in a nationwide audit. Dis Liver Dis 46: 419-426, 2014.","DOI":"10.1016\/j.dld.2013.12.010"},{"key":"3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","volume":"80","author":"DY Graham","year":"1981","unstructured":"3. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 80: 800-809, 1981.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Augustin S, Muntaner L, Altamirano JT, et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol 7: 1347-1354, 2009.","DOI":"10.1016\/j.cgh.2009.08.011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Augustin S, Altamirano J, Gonzalez A, et al. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol 106: 1787-1795, 2011.","DOI":"10.1038\/ajg.2011.173"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Abraldes JG, Villanueva C, Banares R, et al. Spanish cooperative group for portal hypertension and variceal bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 48: 229-236, 2008.","DOI":"10.1016\/j.jhep.2007.10.008"},{"key":"7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","volume":"38","author":"G D'Amico","year":"2003","unstructured":"7. D&apos;Amico G, de Franchis R. Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38: 599-612, 2003.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117: 627-631, 1999.","DOI":"10.1016\/S0016-5085(99)70455-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 146: 412-419, 2014.","DOI":"10.1053\/j.gastro.2013.10.018"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. North Italian Endoscopic Club for the Study, Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 319: 983-989, 1988.","DOI":"10.1056\/NEJM198810133191505"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Garcia-Pagan JC, Caca K, Bureau C, et al. Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362: 2370-2379, 2010.","DOI":"10.1056\/NEJMoa0910102"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effect of induced hyperammonia in cirrhosis. J Hepatol 40: 247-254, 2004.","DOI":"10.1016\/j.jhep.2003.10.016"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salemo F. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 51: 475-482, 2009.","DOI":"10.1016\/j.jhep.2009.04.017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Thabut D, Massard J, Gangloff A, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 46: 1872-1882, 2007.","DOI":"10.1002\/hep.21920"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27: 1227-1232, 1998.","DOI":"10.1002\/hep.510270507"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8: R234-R242, 2004.","DOI":"10.1186\/cc2877"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chauveau P, Level C, Lasseur C, et al. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study. J Ren Nutr 13: 137-143, 2003.","DOI":"10.1053\/jren.2003.50017"},{"key":"18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.burns.2006.07.001","volume":"33","author":"A Lavrentieva","year":"2007","unstructured":"18. Lavrentieva A, Kontakiotis T, Lazarids L, et al. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns 33: 189-194, 2007.","journal-title":"Burns","ISSN":"https:\/\/id.crossref.org\/issn\/0305-4179","issn-type":"print"},{"key":"19","unstructured":"19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. Springer, New York, 2010."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tajiri T, Yoshida H, Obara K, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 22: 1-9, 2010.","DOI":"10.1111\/j.1443-1661.2009.00929.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63: 743-752, 2015.","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Amitrano L, Guardascione MA, Manguso F, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol 107: 1872-1878, 2012.","DOI":"10.1038\/ajg.2012.313"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predicters of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 57: 814-820, 2008.","DOI":"10.1136\/gut.2007.137489"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 146: 412-419, 2014.","DOI":"10.1053\/j.gastro.2013.10.018"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tandon P, Abraldes JG, Keough A, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics. Clin Gastroenterol Hepatol 13: 1189-1196, 2015.","DOI":"10.1016\/j.cgh.2014.11.019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cho H, Nagata N, Shimbo T, et al. Recurrence and prognosis of patients emergently hospitalized for acute esophageal variceal bleeding: a long-term cohort study. Hepatol Res 46: 1338-1346, 2016.","DOI":"10.1111\/hepr.12692"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kanda Y. Investigation of the freely available easy -to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 102: 1510-1517, 2007.","DOI":"10.1111\/j.1572-0241.2007.01286.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Fortune BE, Garcia-Tsao G, Cialeblio M, et al.; Vapreotide Study Group. Child-Turcotte-Pugh class is the best at stratifying risk in variceal hemorrhage: analysis of a US multicenter prospective study. J Clin Gastroenterol 51: 446-453, 2017.","DOI":"10.1097\/MCG.0000000000000733"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Papatheodoridis GV, Cholongitas E, Dimitriadou E, et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 11: 3099-4104, 2005.","DOI":"10.3748\/wjg.v11.i20.3099"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Park WB, Lee KD, Lee CS, et al. Production of C-reactive protein in <i>Escherichia coli<\/i>-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis 51: 227-230, 2005.","DOI":"10.1016\/j.diagmicrobio.2004.11.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 146: 347-351, 2005.","DOI":"10.1016\/j.lab.2005.08.005"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Cervoni JP, Thevenot T, Weil D, et al. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol 56: 1299-1304, 2012.","DOI":"10.1016\/j.jhep.2011.12.030"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cirera I, Bauer TM, Navasa M, et al. Baacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 34: 32-37, 2001.","DOI":"10.1016\/S0168-8278(00)00013-1"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammation response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40: 247-254, 2004.","DOI":"10.1016\/j.jhep.2003.10.016"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salemo F. The systemic inflammatory response syndrome in cirrhotic patients; relationship with their in-hospital outcome. J Hepatol 51: 475-482, 2009.","DOI":"10.1016\/j.jhep.2009.04.017"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 48: 2064-2077, 2008.","DOI":"10.1002\/hep.22605"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Fagundes C, Barreto R, Guevara M, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol 59: 474-481, 2013.","DOI":"10.1016\/j.jhep.2013.04.036"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver disease. Hepatology 65: 310-335, 2017.","DOI":"10.1002\/hep.28906"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Hidaka H, Nakazawa T, Wang G, et al. Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial. J Gastroenterol 47: 118-126, 2012.","DOI":"10.1007\/s00535-011-0472-0"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Cho H, Nagata N, Shimbo T, et al. Recurrence and prognosis of patients emergently hospitalized for acute esophageal variceal bleeding: a long-term cohort study. Hepatol Res 46: 1338-1346, 2016.","DOI":"10.1111\/hepr.12692"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Sieghart W, Pinter M, Hucke F, et al. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma. Hepatology 57: 2224-2234, 2013.","DOI":"10.1002\/hep.26057"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/4\/58_1447-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T23:05:09Z","timestamp":1572131109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/4\/58_1447-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1447-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]}}}